Patient P-02518

Synthetic patientMETA-24 · Day 171 · 25–34 · M · baseline S17Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Favorable

GI state

Improving

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

14%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S17
Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.
Day 32 DT-01 recommended — Dosing / Timing Recommendation DT-01
Day 33 Patient accepted — Started DT-01 in the companion
Day 38 GI symptom burden −11% vs expected — Dosing / Timing Recommendation DT-01
Day 44 Tolerance state changed — Unstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 13.

Primary contributors, last 14 days

Inflammatory activity-10
GI instability-9
Nutritional resilience+4
Toxicity-2

What helped?

Dosing / Timing Recommendation DT-01Day 32
Result: symptom burden −11%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

36 min

stable · +0.6 vs previous 14 d

Sleep duration

Wearable

6.6 h

stable · +0.0 vs previous 14 d

Energy level

Daily log

6.2/10

improving · +0.2 vs previous 14 d

Steps

Wearable

3,969

stable · +29 vs previous 14 d

GI burden

Companion

17.7/100

worsening · +5.8 vs previous 14 d

Adherence

Companion

91.7 %

stable · -2.9 vs previous 14 d

Sleep quality

Wearable

33.8/100

stable · +0.6 vs previous 14 d

Glucose, CGM daily mean

CGM

128 mg/dL

stable · +2.7 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 83 from the failing basin, 10 from restoration.

Good elements to keep

Protein (supports)
perturbation · steering +9.2
Dosing / Timing Recommendation DT-01
intervention · steering +8.8
Butyrate producers intact
hidden · steering +7.5
Daily walks resumed
perturbation · steering +3.3
Protein
supporter · GI -4.7 next day

Main detractors to watch

Antibiotic course
perturbation · steering -4.7
Dietary drift
perturbation · steering -2.6
Alcohol on dosing days
perturbation · steering -1.8

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-4.7supporter · 95%
Insoluble fibre
-2.4no signal · 50%
Caffeine
-2.4no signal · 41%
Ultra-processed food
+1.9no signal · 35%
Alcohol
-0.7no signal · 15%
Dietary fat load
-0.6no signal · 15%
Histamine load
+0.6no signal · 15%
Simple carbohydrates
+0.5no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓20
- Wearable3,969 steps/day
Inflammatory signalling ↓15
- WearableHRV 33 ms, trending down

DNA

Fictional pharmacogenomic panel

CYP2D6 Intermediate metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 4 · butyrate capacity 49/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 34 ms
Sleep: 6.3 h
Steps: 4,632
Resting HR: 72 bpm

Daily log: GI score 18, nutritional resilience 65, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02483	40%	S06	BR-03	no change	64
P-02267	35%	S09	BR-03	no change	45
P-02280	33%	S07	BR-03	no change	50
P-02282	33%	S01	BR-03	no change	88
P-02354	44%	S01	CR-01	improved	78
P-02491	45%	S09	DT-01	no change	65
P-02462	44%	S12	DT-01	improved	65
P-02330	41%	S15	DT-01	no change	57
P-02126	40%	S16	DT-01	improved	59
P-02235	38%	S14	DT-01	improved	50
P-02218	37%	S01	DT-01	improved	61
P-02274	37%	S15	DT-01	improved	50